Examkin

Soru

Zorluk: OrtaGastroenterology and Hepatology

A 45-year-old man presents to the clinic for chronic diarrhea and recurrent severe abdominal pain for the past 6 months. He states that he has been taking high-dose over-the-counter omeprazole with minimal relief. Vital signs are within normal limits. Physical examination reveals mild epigastric tenderness to deep palpation. An upper gastrointestinal endoscopy is performed, revealing prominent gastric folds and multiple ulcerations in the gastric body, duodenal bulb, and distal duodenum. A gastric aspirate obtained during the endoscopy shows a pH of 1.4. The physician suspects a neuroendocrine tumor as the underlying cause of the patient's presentation.

Arrange the following subsequent steps in the most appropriate chronological sequence for the definitive diagnosis and management of this patient's suspected condition.

  1. 1Measure fasting serum gastrin level
  2. 2Perform a secretin stimulation test
  3. 3Perform somatostatin receptor scintigraphy
  4. 4Perform surgical resection of the tumor

Cevap

The correct sequence for the diagnosis and management of Zollinger-Ellison syndrome is: (1) Measure fasting serum gastrin level, (2) Perform a secretin stimulation test, (3) Perform somatostatin receptor scintigraphy, and (4) Perform surgical resection of the tumor.
The diagnostic workup for Zollinger-Ellison syndrome (ZES) must proceed in a logical, step-wise fashion to ensure diagnostic accuracy and avoid unnecessary procedures. First, the presence of inappropriate gastrin secretion must be established. The initial screening test is a fasting serum gastrin level. If the level is markedly elevated (>1000 pg/mL) in the presence of an acidic gastric pH (<2.0), the diagnosis is confirmed. However, if the gastrin level is moderately elevated (e.g., 110-1000 pg/mL), a secretin stimulation test is required. Normal gastric G cells are inhibited by secretin, whereas gastrinoma cells are paradoxically stimulated, resulting in a marked rise in serum gastrin. Only after biochemical confirmation of a gastrinoma should imaging be performed to localize the tumor. Somatostatin receptor scintigraphy (OctreoScan) or endoscopic ultrasound are the modalities of choice because gastrinomas highly express somatostatin receptors. Finally, once the tumor is biochemically confirmed and anatomically localized, surgical resection is performed for definitive management, assuming the absence of diffuse metastatic disease.

Adım Adım Çözüm

1
Measure fasting serum gastrin level
Detects inappropriate hypergastrinemia.
This is the initial biochemical screening test required to confirm the presence of excess gastrin secretion.
2
Perform a secretin stimulation test
Differentiates gastrinoma from physiologic gastrin elevation.
Normal gastric G cells are inhibited by secretin, but gastrinoma cells are paradoxically stimulated. This confirms the diagnosis if initial gastrin levels are non-diagnostic (110-1000 pg/mL).
3
Perform somatostatin receptor scintigraphy
Localizes the tumor anatomically.
Imaging should only be performed after biochemical confirmation. Gastrinomas typically express high levels of somatostatin receptors.
4
Perform surgical resection of the tumor
Provides definitive management.
Curative surgical excision is indicated for localized gastrinomas without diffuse metastatic disease.

Anahtar Kavram

The evaluation of suspected Zollinger-Ellison syndrome (gastrinoma) proceeds stepwise: initial biochemical screening with fasting gastrin, confirmatory testing with secretin stimulation if needed, anatomical localization via advanced imaging, and definitive surgical resection.
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru